10 Best Small Cap Stocks to Buy Now - 1 of 10

 
 

ChromaDex (NASDAQ:CDXC)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$6.20 (74.6% Upside)

About ChromaDex

ChromaDex logoChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/9/2024HC WainwrightReiterated RatingBuy ➝ Buy$6.00
4/9/2024Roth MkmBoost Price TargetBuy ➝ Buy$4.25 ➝ $6.00
8/10/2023HC WainwrightReiterated RatingBuy ➝ Buy$5.00
5/11/2023LADENBURG THALM/SH SHLower Price Target$7.50 ➝ $6.60
3/13/2023HC WainwrightLower Price TargetBuy$5.50 ➝ $5.00
2/1/2023HC WainwrightReiterated RatingBuy$5.50
11/3/2022B. RileyLower Price Target$2.40 ➝ $2.10
8/29/2022HC WainwrightLower Price TargetBuy$7.00 ➝ $5.50
8/16/2022OppenheimerDowngradeOutperform ➝ Market Perform
8/11/2022B. RileyDowngradeBuy ➝ Neutral$6.00 ➝ $2.40
 

Trump’s “Tax Free” Retirement Strategy (Ad)

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…